Where our team of guest writers discuss what they think about the current NGP US Issues.
Jussi Halleen and Rami Käkönen, Pharmatest Services Ltd
The CRO is managing a pivotal Phase III study involving more than 2500 malaria patients in Asia and Africa
Competitive pressures are forcing the pharmaceutical and biotechnology industries to become more efficient when developing new products.
By John R. Schoenfelder, Ph.D., Dolores R. Massari, and Margaret E. Hurley, M.D.
By Christopher Sprague.
As a life sciences company, your goal is to safely speed products to market while meeting your regulatory obligations.